Resveratrol-induced SIRT1 activation inhibits glycolysis-fueled angiogenesis under rheumatoid arthritis conditions independent of HIF-1α

Objective This study investigated the impacts of SIRT1 activation on rheumatoid arthritis (RA)-related angiogenesis. Methods HUVECs were cultured by different human serum. Intracellular metabolites were quantified by UPLC-MS. Next, HUVECs and rat vascular epithelial cells under different inflammator...

Full description

Saved in:
Bibliographic Details
Published inInflammation research Vol. 72; no. 5; pp. 1021 - 1035
Main Authors Jiang, Tian-Tian, Ji, Cong-Lan, Yu, Li-Jun, Song, Meng-Ke, Li, Yan, Liao, Qiang, Wei, Tuo, Olatunji, Opeyemi Joshua, Zuo, Jian, Han, Jun
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.05.2023
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective This study investigated the impacts of SIRT1 activation on rheumatoid arthritis (RA)-related angiogenesis. Methods HUVECs were cultured by different human serum. Intracellular metabolites were quantified by UPLC-MS. Next, HUVECs and rat vascular epithelial cells under different inflammatory conditions were treated by a SIRT1 agonist resveratrol (RSV). Cytokines and biochemical indicators were detected by corresponding kits. Protein and mRNA expression levels were assessed by immunoblotting and PCR methods, respectively. Angiogenesis capabilities were evaluated by migration, wound-healing and tube-formation experiments. To down-regulate certain signals, gene-specific siRNA were applied. Results Metabolomics study revealed the accelerated glycolysis in RA serum-treated HUVECs. It led to ATP accumulation, but did not affect GTP levels. RSV inhibited pro-angiogenesis cytokines production and glycolysis in both the cells, and impaired the angiogenesis potentials. These effects were mimicked by an energy metabolism interrupter bikini in lipopolysaccharide (LPS)-primed HUVECs, largely independent of HIF-1α. Both RSV and bikinin can inhibit the activation of the GTP-dependent pathway Rho/ROCK and reduce VEGF production. Abrogation of RhoA signaling reinforced HIF-1α silencing-brought changes in LPS-stimulated HUVECs, and overshadowed the anti-angiogenesis potentials of RSV. Conclusion Glycolysis provides additional energy to sustain Rho/ROCK activation in RA subjects, which promotes VEGF-driven angiogenesis and can be inhibited by SIRT1 activation.
AbstractList ObjectiveThis study investigated the impacts of SIRT1 activation on rheumatoid arthritis (RA)-related angiogenesis.MethodsHUVECs were cultured by different human serum. Intracellular metabolites were quantified by UPLC-MS. Next, HUVECs and rat vascular epithelial cells under different inflammatory conditions were treated by a SIRT1 agonist resveratrol (RSV). Cytokines and biochemical indicators were detected by corresponding kits. Protein and mRNA expression levels were assessed by immunoblotting and PCR methods, respectively. Angiogenesis capabilities were evaluated by migration, wound-healing and tube-formation experiments. To down-regulate certain signals, gene-specific siRNA were applied.ResultsMetabolomics study revealed the accelerated glycolysis in RA serum-treated HUVECs. It led to ATP accumulation, but did not affect GTP levels. RSV inhibited pro-angiogenesis cytokines production and glycolysis in both the cells, and impaired the angiogenesis potentials. These effects were mimicked by an energy metabolism interrupter bikini in lipopolysaccharide (LPS)-primed HUVECs, largely independent of HIF-1α. Both RSV and bikinin can inhibit the activation of the GTP-dependent pathway Rho/ROCK and reduce VEGF production. Abrogation of RhoA signaling reinforced HIF-1α silencing-brought changes in LPS-stimulated HUVECs, and overshadowed the anti-angiogenesis potentials of RSV.ConclusionGlycolysis provides additional energy to sustain Rho/ROCK activation in RA subjects, which promotes VEGF-driven angiogenesis and can be inhibited by SIRT1 activation.
Objective This study investigated the impacts of SIRT1 activation on rheumatoid arthritis (RA)-related angiogenesis. Methods HUVECs were cultured by different human serum. Intracellular metabolites were quantified by UPLC-MS. Next, HUVECs and rat vascular epithelial cells under different inflammatory conditions were treated by a SIRT1 agonist resveratrol (RSV). Cytokines and biochemical indicators were detected by corresponding kits. Protein and mRNA expression levels were assessed by immunoblotting and PCR methods, respectively. Angiogenesis capabilities were evaluated by migration, wound-healing and tube-formation experiments. To down-regulate certain signals, gene-specific siRNA were applied. Results Metabolomics study revealed the accelerated glycolysis in RA serum-treated HUVECs. It led to ATP accumulation, but did not affect GTP levels. RSV inhibited pro-angiogenesis cytokines production and glycolysis in both the cells, and impaired the angiogenesis potentials. These effects were mimicked by an energy metabolism interrupter bikini in lipopolysaccharide (LPS)-primed HUVECs, largely independent of HIF-1α. Both RSV and bikinin can inhibit the activation of the GTP-dependent pathway Rho/ROCK and reduce VEGF production. Abrogation of RhoA signaling reinforced HIF-1α silencing-brought changes in LPS-stimulated HUVECs, and overshadowed the anti-angiogenesis potentials of RSV. Conclusion Glycolysis provides additional energy to sustain Rho/ROCK activation in RA subjects, which promotes VEGF-driven angiogenesis and can be inhibited by SIRT1 activation.
This study investigated the impacts of SIRT1 activation on rheumatoid arthritis (RA)-related angiogenesis.OBJECTIVEThis study investigated the impacts of SIRT1 activation on rheumatoid arthritis (RA)-related angiogenesis.HUVECs were cultured by different human serum. Intracellular metabolites were quantified by UPLC-MS. Next, HUVECs and rat vascular epithelial cells under different inflammatory conditions were treated by a SIRT1 agonist resveratrol (RSV). Cytokines and biochemical indicators were detected by corresponding kits. Protein and mRNA expression levels were assessed by immunoblotting and PCR methods, respectively. Angiogenesis capabilities were evaluated by migration, wound-healing and tube-formation experiments. To down-regulate certain signals, gene-specific siRNA were applied.METHODSHUVECs were cultured by different human serum. Intracellular metabolites were quantified by UPLC-MS. Next, HUVECs and rat vascular epithelial cells under different inflammatory conditions were treated by a SIRT1 agonist resveratrol (RSV). Cytokines and biochemical indicators were detected by corresponding kits. Protein and mRNA expression levels were assessed by immunoblotting and PCR methods, respectively. Angiogenesis capabilities were evaluated by migration, wound-healing and tube-formation experiments. To down-regulate certain signals, gene-specific siRNA were applied.Metabolomics study revealed the accelerated glycolysis in RA serum-treated HUVECs. It led to ATP accumulation, but did not affect GTP levels. RSV inhibited pro-angiogenesis cytokines production and glycolysis in both the cells, and impaired the angiogenesis potentials. These effects were mimicked by an energy metabolism interrupter bikini in lipopolysaccharide (LPS)-primed HUVECs, largely independent of HIF-1α. Both RSV and bikinin can inhibit the activation of the GTP-dependent pathway Rho/ROCK and reduce VEGF production. Abrogation of RhoA signaling reinforced HIF-1α silencing-brought changes in LPS-stimulated HUVECs, and overshadowed the anti-angiogenesis potentials of RSV.RESULTSMetabolomics study revealed the accelerated glycolysis in RA serum-treated HUVECs. It led to ATP accumulation, but did not affect GTP levels. RSV inhibited pro-angiogenesis cytokines production and glycolysis in both the cells, and impaired the angiogenesis potentials. These effects were mimicked by an energy metabolism interrupter bikini in lipopolysaccharide (LPS)-primed HUVECs, largely independent of HIF-1α. Both RSV and bikinin can inhibit the activation of the GTP-dependent pathway Rho/ROCK and reduce VEGF production. Abrogation of RhoA signaling reinforced HIF-1α silencing-brought changes in LPS-stimulated HUVECs, and overshadowed the anti-angiogenesis potentials of RSV.Glycolysis provides additional energy to sustain Rho/ROCK activation in RA subjects, which promotes VEGF-driven angiogenesis and can be inhibited by SIRT1 activation.CONCLUSIONGlycolysis provides additional energy to sustain Rho/ROCK activation in RA subjects, which promotes VEGF-driven angiogenesis and can be inhibited by SIRT1 activation.
This study investigated the impacts of SIRT1 activation on rheumatoid arthritis (RA)-related angiogenesis. HUVECs were cultured by different human serum. Intracellular metabolites were quantified by UPLC-MS. Next, HUVECs and rat vascular epithelial cells under different inflammatory conditions were treated by a SIRT1 agonist resveratrol (RSV). Cytokines and biochemical indicators were detected by corresponding kits. Protein and mRNA expression levels were assessed by immunoblotting and PCR methods, respectively. Angiogenesis capabilities were evaluated by migration, wound-healing and tube-formation experiments. To down-regulate certain signals, gene-specific siRNA were applied. Metabolomics study revealed the accelerated glycolysis in RA serum-treated HUVECs. It led to ATP accumulation, but did not affect GTP levels. RSV inhibited pro-angiogenesis cytokines production and glycolysis in both the cells, and impaired the angiogenesis potentials. These effects were mimicked by an energy metabolism interrupter bikini in lipopolysaccharide (LPS)-primed HUVECs, largely independent of HIF-1α. Both RSV and bikinin can inhibit the activation of the GTP-dependent pathway Rho/ROCK and reduce VEGF production. Abrogation of RhoA signaling reinforced HIF-1α silencing-brought changes in LPS-stimulated HUVECs, and overshadowed the anti-angiogenesis potentials of RSV. Glycolysis provides additional energy to sustain Rho/ROCK activation in RA subjects, which promotes VEGF-driven angiogenesis and can be inhibited by SIRT1 activation.
Author Zuo, Jian
Yu, Li-Jun
Jiang, Tian-Tian
Li, Yan
Ji, Cong-Lan
Liao, Qiang
Wei, Tuo
Olatunji, Opeyemi Joshua
Han, Jun
Song, Meng-Ke
Author_xml – sequence: 1
  givenname: Tian-Tian
  surname: Jiang
  fullname: Jiang, Tian-Tian
  organization: Xin’an Medicine Research Center, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital)
– sequence: 2
  givenname: Cong-Lan
  surname: Ji
  fullname: Ji, Cong-Lan
  organization: School of Pharmacy, Anhui College of Traditional Chinese Medicine
– sequence: 3
  givenname: Li-Jun
  surname: Yu
  fullname: Yu, Li-Jun
  organization: Xin’an Medicine Research Center, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), Research Center of Integration of Traditional Chinese and Western Medicine, Wannan Medical College
– sequence: 4
  givenname: Meng-Ke
  surname: Song
  fullname: Song, Meng-Ke
  organization: Xin’an Medicine Research Center, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), Research Center of Integration of Traditional Chinese and Western Medicine, Wannan Medical College
– sequence: 5
  givenname: Yan
  surname: Li
  fullname: Li, Yan
  organization: Xin’an Medicine Research Center, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital)
– sequence: 6
  givenname: Qiang
  surname: Liao
  fullname: Liao, Qiang
  organization: Xin’an Medicine Research Center, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), Research Center of Integration of Traditional Chinese and Western Medicine, Wannan Medical College
– sequence: 7
  givenname: Tuo
  surname: Wei
  fullname: Wei, Tuo
  organization: Xin’an Medicine Research Center, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital)
– sequence: 8
  givenname: Opeyemi Joshua
  surname: Olatunji
  fullname: Olatunji, Opeyemi Joshua
  organization: African Genome Center, Mohammed VI Polytechnic University
– sequence: 9
  givenname: Jian
  surname: Zuo
  fullname: Zuo, Jian
  email: zuojian8178@163.com
  organization: Xin’an Medicine Research Center, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), Center for Xin’an Medicine and Modernization of Traditional Chinese Medicine, Institution of Health and Medicine, Hefei Comprehensive National Science Center, Anhui Provincial Engineering Laboratory for Screening and Re-Evaluation of Active Compounds of Herbal Medicines in Southern Anhui
– sequence: 10
  givenname: Jun
  surname: Han
  fullname: Han, Jun
  email: hanjun@wnmc.edu.cn
  organization: Anhui Provincial Engineering Laboratory for Screening and Re-Evaluation of Active Compounds of Herbal Medicines in Southern Anhui, School of Pharmacy, Wannan Medical College
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37016140$$D View this record in MEDLINE/PubMed
BookMark eNp9kd9uFCEYxYmpsX_0Bbwwk3jjDcqfmYG5NI21mzRpUmviHWHgY5dmFlZg2uwj-Di-iM8k26016UVvgHB-5_CFc4wOQgyA0FtKPlJCxKdMCKEUE8YxoYJJfPcCHdGWETwQ-eOgnncSl5wcouOcbyoumWSv0CEXhPa0JUfo1xXkW0i6pDhhH-xswDbfFlfXtNGm-FtdfAyNDys_-pKb5bQ1cdpmn7GbYaqsDksflxCg3jVzsJCatIJ5rUv0VU1llXypkonB-l1YrmkWNlCXUJromvPFGaZ_fr9GL52eMrx52E_Q97Mv16fn-OLy6-L08wU2XHQFD07aTo8jF7QznHKhNQATtueiHaQVg-u1FoK0RAtj3GjN2DnHHWW6s67n_AR92OduUvw5Qy5q7bOBadIB4pwVE0NPO9mJvqLvn6A3cU6hTqeYrEzLulZU6t0DNY9rsGqT_Fqnrfr3yRVge8CkmHMC94hQonZNqn2Tqtal7ptUd9Ukn5iML_dtlKT99LyV7625vhOWkP6P_YzrL_zNtnY
CitedBy_id crossref_primary_10_1186_s13020_023_00833_6
crossref_primary_10_1007_s10787_024_01612_x
crossref_primary_10_3389_fvets_2025_1548866
crossref_primary_10_1016_j_jep_2024_118061
crossref_primary_10_3390_epigenomes9010002
crossref_primary_10_1016_j_heliyon_2024_e37371
crossref_primary_10_3390_biology13080598
crossref_primary_10_1016_j_intimp_2024_111913
crossref_primary_10_1002_ptr_8184
crossref_primary_10_2147_JIR_S474329
crossref_primary_10_3389_fphar_2024_1403823
crossref_primary_10_2147_JIR_S431600
Cites_doi 10.1016/j.canlet.2019.08.003
10.3389/fphar.2021.785586
10.1016/j.foodchem.2018.04.096
10.1016/j.canlet.2017.12.035
10.3389/fphar.2018.01472
10.3390/cancers13194987
10.1002/1873-3468.13087
10.2147/JIR.S378090
10.1007/s10911-006-9002-8
10.1038/s41580-020-0227-y
10.1021/acs.jafc.8b05047
10.1155/2020/3830212
10.1111/bph.13492
10.1016/j.biopha.2021.111693
10.3389/fnins.2018.00911
10.3389/fphar.2019.00421
10.3389/fimmu.2021.686155
10.1152/physrev.00001.2017
10.1016/j.jaut.2019.102400
10.1001/jama.2018.13103
10.1126/scisignal.aal3024
10.1161/STROKEAHA.117.018562
10.1038/s41419-018-0570-5
10.1016/j.ejphar.2021.174500
10.1182/blood-2013-09-512749
10.1016/j.abb.2018.11.016
10.1002/biof.1599
10.1007/s00005-011-0116-3
10.3389/fimmu.2021.795626
10.1111/imr.12838
10.1155/2017/7543973
10.7150/thno.30305
10.3389/fcvm.2021.775392
10.7326/AITC201901010
10.21037/atm-22-1221
10.3390/molecules26247528
10.2147/JIR.S295957
10.1016/j.cmet.2017.10.005
10.2174/1871530315666150316120316
10.1002/ptr.6175
10.1301/nr.2007.dec.S140-S146
10.1111/jfbc.14182
10.3390/nu14235101
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7T5
7T7
7TM
7TO
7U9
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
C1K
CCPQU
FR3
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
DOI 10.1007/s00011-023-01728-w
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Oncogenes and Growth Factors Abstracts
Technology Research Database
ProQuest One Academic Middle East (New)
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Oncogenes and Growth Factors Abstracts

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central Database Suite (ProQuest)
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1420-908X
EndPage 1035
ExternalDocumentID 37016140
10_1007_s00011_023_01728_w
Genre Journal Article
GrantInformation_xml – fundername: Key Project of Natural Science Foundation of Anhui Province for College Scholar
  grantid: KJ2020A0868
– fundername: National Natural Science Foundation of China
  grantid: 81973828, 82274465
– fundername: the Open Fund of Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, China (Anhui Medical University)
  grantid: KFJJ-2020-08
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
2.D
203
28-
29I
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3O-
3SX
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67N
67Z
6NX
78A
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACZOJ
ADBBV
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EN4
EPAXT
ESBYG
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
PF0
PKN
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WH7
WJK
WK6
WK8
X7M
Y6R
YLTOR
Z45
Z7U
Z7W
Z82
Z87
Z8O
Z8Q
Z8V
Z91
ZGI
ZMTXR
ZOVNA
ZXP
~EX
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T5
7T7
7TM
7TO
7U9
7XB
8FD
8FK
ABRTQ
C1K
FR3
H94
K9.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
7X8
ID FETCH-LOGICAL-c375t-9f8d5abb3715c3137aaee27d637498d79f6aa77040a7ccfbdcb5ff3f12a5df633
IEDL.DBID 7X7
ISSN 1023-3830
1420-908X
IngestDate Fri Jul 11 04:55:19 EDT 2025
Sat Aug 23 13:03:57 EDT 2025
Wed Feb 19 02:24:06 EST 2025
Tue Jul 01 01:43:54 EDT 2025
Thu Apr 24 22:58:14 EDT 2025
Fri Feb 21 02:44:37 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Glucose metabolism
GTP
Bikinin
Rho/ROCK
VEGF
Language English
License 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c375t-9f8d5abb3715c3137aaee27d637498d79f6aa77040a7ccfbdcb5ff3f12a5df633
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 37016140
PQID 2815842547
PQPubID 24296
PageCount 15
ParticipantIDs proquest_miscellaneous_2796158576
proquest_journals_2815842547
pubmed_primary_37016140
crossref_primary_10_1007_s00011_023_01728_w
crossref_citationtrail_10_1007_s00011_023_01728_w
springer_journals_10_1007_s00011_023_01728_w
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20230500
2023-05-00
2023-May
20230501
PublicationDateYYYYMMDD 2023-05-01
PublicationDate_xml – month: 5
  year: 2023
  text: 20230500
PublicationDecade 2020
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: Switzerland
– name: New York
PublicationSubtitle Official Journal of: The International Association of Inflammation Societies + The European Histamine Research Society
PublicationTitle Inflammation research
PublicationTitleAbbrev Inflamm. Res
PublicationTitleAlternate Inflamm Res
PublicationYear 2023
Publisher Springer International Publishing
Springer Nature B.V
Publisher_xml – name: Springer International Publishing
– name: Springer Nature B.V
References Yu, Dong, Li, Liu (CR16) 2018; 418
Yang, Chang, Yang, Yuan, Xu, Ho, Li (CR24) 2018; 66
Jaklová Dytrtová, Straka, Bělonožníková, Jakl, Ryšlavá (CR18) 2018; 262
Merajver, Usmani (CR27) 2005; 10
Scherer, Häupl, Burmester (CR2) 2020; 110
Weyand, Goronzy (CR30) 2020; 294
Jia, Wu, Yang, Xiao, Huang, Long, Su (CR7) 2018; 9
Wang, Xie, Yuan, Qiu, Duan, Xu, Chen (CR23) 2020; 46
Zhu, Xie, Wang, Jin, Meng, Sun, Sun (CR33) 2021; 140
Inoue, Nakata (CR22) 2015; 15
Nazari-Khanamiri, Ghasemnejad-Berenji (CR31) 2022; 46
Rameshrad, Imenshahidi, Razavi, Iranshahi, Hosseinzadeh (CR26) 2018; 32
Jiang, Ji, Cheng, Gu, Wang, Li, Zuo, Han (CR13) 2021; 12
Xia, Daiber, Förstermann, Li (CR17) 2017; 174
Kim, Byzova (CR39) 2014; 123
Zuo, Wang, Liu, Ye, Liu, Li, Li (CR42) 2018; 9
Kretschmer, Rüdiger, Zahler (CR11) 2021; 13
Libby (CR29) 2007; 65
Huang, Fu, Chen, Li, Huang, Liang (CR6) 2021; 12
Koronowski, Khoury, Saul, Loris, Cohan, Stradecki-Cohan, Dave (CR21) 2017; 48
Choudhry, Harris (CR10) 2018; 27
Lei, Tao, Wu, Xu, Yang, Li, Olatunji (CR15) 2022; 12
Zhang, Huang, Zeng, Wu, Zhang, Chen (CR38) 2017; 2017
Wang, He, Wu, Xu, Shi, Olatunji, Zuo (CR14) 2022; 15
Zheng, Shan, Xu, Wang, Shi, Wang, Zheng (CR34) 2018; 12
Liu, Pang, Ji, Fang, Tian, Chen, Chen (CR25) 2022; 8
Zuo, Tao, Wu, Jiang, Olatunji, Dong, Han (CR43) 2021; 14
Fang, Zhou, Nandakumar (CR4) 2020; 2020
Aletaha, Smolen (CR5) 2018; 320
Craveiro, Cretenet, Mongellaz, Matias, Caron, de Lima, Zimmermann (CR20) 2017; 10
Liu, Wada, Katsura, Tozawa, Erwin, Kapron, Bao (CR41) 2018; 8
Fan, Liu, Guo, Huang, Peng, Li, Luo (CR36) 2021; 26
Lee, Chandel, Simon (CR9) 2020; 21
Sparks (CR3) 2019; 170
Shiozawa, Tsumiyama, Yoshida, Hashiramoto (CR1) 2011; 59
Li, Wu, Han, Wang, Bai, Jia, Li (CR35) 2019; 661
Grzeczka, Kordowitzki (CR19) 2022; 14
Eelen, de Zeeuw, Treps, Harjes, Wong, Carmeliet (CR12) 2018; 98
Fang, Zhang, Liu, Zhang, Zhu, Li, Wang (CR28) 2019; 463
Huang, Sun, Chen, Niu, Wang, Zhao, Sun (CR37) 2019; 10
Narumiya, Thumkeo (CR40) 2018; 592
Peng, Wei, Huang, Yan, Li, Li, Wu (CR32) 2022; 10
Wang, Wu, Deng (CR8) 2021; 910
P Libby (1728_CR29) 2007; 65
F Nazari-Khanamiri (1728_CR31) 2022; 46
J Zuo (1728_CR42) 2018; 9
H Choudhry (1728_CR10) 2018; 27
KB Koronowski (1728_CR21) 2017; 48
M Rameshrad (1728_CR26) 2018; 32
P Lee (1728_CR9) 2020; 21
J Huang (1728_CR6) 2021; 12
TT Jiang (1728_CR13) 2021; 12
W Zhang (1728_CR38) 2017; 2017
DD Wang (1728_CR14) 2022; 15
Q Yu (1728_CR16) 2018; 418
T Zhu (1728_CR33) 2021; 140
W Jia (1728_CR7) 2018; 9
M Lei (1728_CR15) 2022; 12
SD Merajver (1728_CR27) 2005; 10
X Huang (1728_CR37) 2019; 10
J Zuo (1728_CR43) 2021; 14
N Xia (1728_CR17) 2017; 174
JA Sparks (1728_CR3) 2019; 170
CM Weyand (1728_CR30) 2020; 294
G Eelen (1728_CR12) 2018; 98
H Inoue (1728_CR22) 2015; 15
Q Fang (1728_CR4) 2020; 2020
YW Kim (1728_CR39) 2014; 123
A Grzeczka (1728_CR19) 2022; 14
G Wang (1728_CR23) 2020; 46
H Peng (1728_CR32) 2022; 10
XW Zheng (1728_CR34) 2018; 12
S Narumiya (1728_CR40) 2018; 592
J Liu (1728_CR41) 2018; 8
J Jaklová Dytrtová (1728_CR18) 2018; 262
B Liu (1728_CR25) 2022; 8
D Fan (1728_CR36) 2021; 26
G Yang (1728_CR24) 2018; 66
X Li (1728_CR35) 2019; 661
M Craveiro (1728_CR20) 2017; 10
M Kretschmer (1728_CR11) 2021; 13
Y Wang (1728_CR8) 2021; 910
HU Scherer (1728_CR2) 2020; 110
D Aletaha (1728_CR5) 2018; 320
S Shiozawa (1728_CR1) 2011; 59
G Fang (1728_CR28) 2019; 463
References_xml – volume: 463
  start-page: 11
  year: 2019
  end-page: 26
  ident: CR28
  article-title: Inhibition of GSK-3β activity suppresses HCC malignant phenotype by inhibiting glycolysis via activating AMPK/mTOR signaling
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2019.08.003
– volume: 12
  start-page: 785586
  year: 2021
  ident: CR13
  article-title: α-Mangostin alleviated hif-1α-mediated angiogenesis in rats with adjuvant-induced arthritis by suppressing aerobic glycolysis
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2021.785586
– volume: 262
  start-page: 221
  year: 2018
  end-page: 225
  ident: CR18
  article-title: Does resveratrol retain its antioxidative properties in wine? Redox behaviour of resveratrol in the presence of Cu(II) and tebuconazole
  publication-title: Food Chem
  doi: 10.1016/j.foodchem.2018.04.096
– volume: 418
  start-page: 20
  year: 2018
  end-page: 26
  ident: CR16
  article-title: SIRT1 and HIF1α signaling in metabolism and immune responses
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2017.12.035
– volume: 9
  start-page: 1472
  year: 2018
  ident: CR42
  article-title: Integrating network pharmacology and metabolomics study on anti-rheumatic mechanisms and antagonistic effects against methotrexate-induced toxicity of Qing-Luo-Yin
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2018.01472
– volume: 13
  start-page: 4987
  year: 2021
  ident: CR11
  article-title: Mechanical aspects of angiogenesis
  publication-title: Cancers
  doi: 10.3390/cancers13194987
– volume: 592
  start-page: 1763
  year: 2018
  end-page: 1776
  ident: CR40
  article-title: Rho signaling research: history, current status and future directions
  publication-title: FEBS Lett
  doi: 10.1002/1873-3468.13087
– volume: 15
  start-page: 4663
  year: 2022
  end-page: 4675
  ident: CR14
  article-title: AMPK/SIRT1 deficiency drives adjuvant-induced arthritis in rats by promoting glycolysis-mediated monocytes inflammatory polarization
  publication-title: J Inflamm Res
  doi: 10.2147/JIR.S378090
– volume: 10
  start-page: 291
  year: 2005
  end-page: 298
  ident: CR27
  article-title: Multifaceted role of Rho proteins in angiogenesis
  publication-title: J Mammary Gland Biol Neoplasia
  doi: 10.1007/s10911-006-9002-8
– volume: 21
  start-page: 268
  year: 2020
  end-page: 283
  ident: CR9
  article-title: Cellular adaptation to hypoxia through hypoxia inducible factors and beyond
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/s41580-020-0227-y
– volume: 66
  start-page: 12953
  year: 2018
  end-page: 12960
  ident: CR24
  article-title: Resveratrol alleviates rheumatoid arthritis via reducing ROS and inflammation, inhibiting MAPK signaling pathways, and suppressing angiogenesis
  publication-title: J Agric Food Chem
  doi: 10.1021/acs.jafc.8b05047
– volume: 2020
  start-page: 3830212
  year: 2020
  ident: CR4
  article-title: Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis
  publication-title: Mediators Inflamm
  doi: 10.1155/2020/3830212
– volume: 174
  start-page: 1633
  year: 2017
  end-page: 1646
  ident: CR17
  article-title: Antioxidant effects of resveratrol in the cardiovascular system
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.13492
– volume: 140
  start-page: 111693
  year: 2021
  ident: CR33
  article-title: Notoginsenoside R1 activates the NAMPT-NAD -SIRT1 cascade to promote postischemic angiogenesis by modulating Notch signaling
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2021.111693
– volume: 12
  start-page: 911
  year: 2018
  ident: CR34
  article-title: Buyang Huanwu decoction targets SIRT1/VEGF pathway to promote angiogenesis after cerebral ischemia/reperfusion injury
  publication-title: Front Neurosci
  doi: 10.3389/fnins.2018.00911
– volume: 10
  start-page: 421
  year: 2019
  ident: CR37
  article-title: Resveratrol promotes diabetic wound healing via SIRT1-FOXO1-c-Myc signaling pathway-mediated angiogenesis
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2019.00421
– volume: 12
  year: 2021
  ident: CR6
  article-title: Promising therapeutic targets for treatment of rheumatoid arthritis
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.686155
– volume: 98
  start-page: 3
  year: 2018
  end-page: 58
  ident: CR12
  article-title: Endothelial cell metabolism
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00001.2017
– volume: 110
  year: 2020
  ident: CR2
  article-title: The etiology of rheumatoid arthritis
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2019.102400
– volume: 320
  start-page: 1360
  year: 2018
  end-page: 1372
  ident: CR5
  article-title: Diagnosis and management of rheumatoid arthritis: a review
  publication-title: JAMA
  doi: 10.1001/jama.2018.13103
– volume: 10
  start-page: 3024
  year: 2017
  ident: CR20
  article-title: Resveratrol stimulates the metabolic reprogramming of human CD4 T cells to enhance effector function
  publication-title: Sci Signal.
  doi: 10.1126/scisignal.aal3024
– volume: 48
  start-page: 3117
  year: 2017
  end-page: 3125
  ident: CR21
  article-title: Neuronal SIRT1 (silent information regulator 2 homologue 1) regulates glycolysis and mediates resveratrol-induced ischemic tolerance
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.117.018562
– volume: 9
  start-page: 503
  year: 2018
  ident: CR7
  article-title: GATA4 regulates angiogenesis and persistence of inflammation in rheumatoid arthritis
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-018-0570-5
– volume: 910
  year: 2021
  ident: CR8
  article-title: Angiogenesis as a potential treatment strategy for rheumatoid arthritis
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2021.174500
– volume: 123
  start-page: 625
  year: 2014
  end-page: 631
  ident: CR39
  article-title: Oxidative stress in angiogenesis and vascular disease
  publication-title: Blood
  doi: 10.1182/blood-2013-09-512749
– volume: 661
  start-page: 117
  year: 2019
  end-page: 124
  ident: CR35
  article-title: SIRT1 activation promotes angiogenesis in diabetic wounds by protecting endothelial cells against oxidative stress
  publication-title: Arch Biochem Biophys
  doi: 10.1016/j.abb.2018.11.016
– volume: 46
  start-page: 441
  year: 2020
  end-page: 453
  ident: CR23
  article-title: Resveratrol ameliorates rheumatoid arthritis via activation of SIRT1-Nrf2 signaling pathway
  publication-title: BioFactors
  doi: 10.1002/biof.1599
– volume: 59
  start-page: 89
  year: 2011
  end-page: 95
  ident: CR1
  article-title: Pathogenesis of joint destruction in rheumatoid arthritis
  publication-title: Arch Immunol Ther Exp
  doi: 10.1007/s00005-011-0116-3
– volume: 12
  start-page: 795626
  year: 2022
  ident: CR15
  article-title: Metabolic Enzyme Triosephosphate isomerase 1 and nicotinamide phosphoribosyltransferase, two independent inflammatory indicators in rheumatoid arthritis: evidences from collagen-induced arthritis and clinical samples
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.795626
– volume: 294
  start-page: 177
  year: 2020
  end-page: 187
  ident: CR30
  article-title: Immunometabolism in the development of rheumatoid arthritis
  publication-title: Immunol Rev
  doi: 10.1111/imr.12838
– volume: 2017
  start-page: 7543973
  year: 2017
  ident: CR38
  article-title: Sirt1 inhibits oxidative stress in vascular endothelial cells
  publication-title: Oxid Med Cell Longev
  doi: 10.1155/2017/7543973
– volume: 8
  start-page: 6053
  year: 2018
  end-page: 6069
  ident: CR41
  article-title: Rho-associated coiled-coil kinase (ROCK) in molecular regulation of angiogenesis
  publication-title: Theranostics
  doi: 10.7150/thno.30305
– volume: 8
  start-page: 775392
  year: 2022
  ident: CR25
  article-title: MEF2A is the trigger of resveratrol exerting protection on vascular endothelial cell
  publication-title: Front Cardiovasc Med
  doi: 10.3389/fcvm.2021.775392
– volume: 170
  start-page: 1
  year: 2019
  end-page: 16
  ident: CR3
  article-title: Rheumatoid arthritis
  publication-title: Ann Intern Med
  doi: 10.7326/AITC201901010
– volume: 10
  start-page: 446
  year: 2022
  ident: CR32
  article-title: Maternal obesity inhibits placental angiogenesis by down-regulating the SIRT1/PGC-1α pathway
  publication-title: Ann Transl Med
  doi: 10.21037/atm-22-1221
– volume: 26
  start-page: 7528
  year: 2021
  ident: CR36
  article-title: Resveratrol promotes angiogenesis in a FoxO1-dependent manner in hind limb ischemia in mice
  publication-title: Molecules
  doi: 10.3390/molecules26247528
– volume: 14
  start-page: 395
  year: 2021
  end-page: 411
  ident: CR43
  article-title: Securidaca inappendiculata-derived xanthones protected joints from degradation in male rats with collagen-induced arthritis by regulating PPAR-γ signaling
  publication-title: J Inflamm Res
  doi: 10.2147/JIR.S295957
– volume: 27
  start-page: 281
  year: 2018
  end-page: 298
  ident: CR10
  article-title: Advances in hypoxia-inducible factor biology
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2017.10.005
– volume: 15
  start-page: 186
  year: 2015
  end-page: 195
  ident: CR22
  article-title: Resveratrol targets in inflammation
  publication-title: Endocr Metab Immune Disord Drug Targets
  doi: 10.2174/1871530315666150316120316
– volume: 32
  start-page: 2396
  year: 2018
  end-page: 2407
  ident: CR26
  article-title: Bisphenol A vascular toxicity: Protective effect of Vitis vinifera (grape) seed extract and resveratrol
  publication-title: Phytother Res
  doi: 10.1002/ptr.6175
– volume: 65
  start-page: S140
  year: 2007
  end-page: S146
  ident: CR29
  article-title: Inflammatory mechanisms: the molecular basis of inflammation and disease
  publication-title: Nutr Rev
  doi: 10.1301/nr.2007.dec.S140-S146
– volume: 46
  year: 2022
  ident: CR31
  article-title: Resveratrol may ameliorate rheumatoid arthritis via the STAT3/HIF-1/VEGF molecular pathway
  publication-title: J Food Biochem
  doi: 10.1111/jfbc.14182
– volume: 14
  start-page: 5101
  year: 2022
  ident: CR19
  article-title: Resveratrol and SIRT1: Antiaging cornerstones for oocytes?
  publication-title: Nutrients
  doi: 10.3390/nu14235101
– volume: 592
  start-page: 1763
  year: 2018
  ident: 1728_CR40
  publication-title: FEBS Lett
  doi: 10.1002/1873-3468.13087
– volume: 2017
  start-page: 7543973
  year: 2017
  ident: 1728_CR38
  publication-title: Oxid Med Cell Longev
  doi: 10.1155/2017/7543973
– volume: 10
  start-page: 291
  year: 2005
  ident: 1728_CR27
  publication-title: J Mammary Gland Biol Neoplasia
  doi: 10.1007/s10911-006-9002-8
– volume: 320
  start-page: 1360
  year: 2018
  ident: 1728_CR5
  publication-title: JAMA
  doi: 10.1001/jama.2018.13103
– volume: 8
  start-page: 775392
  year: 2022
  ident: 1728_CR25
  publication-title: Front Cardiovasc Med
  doi: 10.3389/fcvm.2021.775392
– volume: 32
  start-page: 2396
  year: 2018
  ident: 1728_CR26
  publication-title: Phytother Res
  doi: 10.1002/ptr.6175
– volume: 294
  start-page: 177
  year: 2020
  ident: 1728_CR30
  publication-title: Immunol Rev
  doi: 10.1111/imr.12838
– volume: 9
  start-page: 503
  year: 2018
  ident: 1728_CR7
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-018-0570-5
– volume: 48
  start-page: 3117
  year: 2017
  ident: 1728_CR21
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.117.018562
– volume: 8
  start-page: 6053
  year: 2018
  ident: 1728_CR41
  publication-title: Theranostics
  doi: 10.7150/thno.30305
– volume: 21
  start-page: 268
  year: 2020
  ident: 1728_CR9
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/s41580-020-0227-y
– volume: 10
  start-page: 421
  year: 2019
  ident: 1728_CR37
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2019.00421
– volume: 262
  start-page: 221
  year: 2018
  ident: 1728_CR18
  publication-title: Food Chem
  doi: 10.1016/j.foodchem.2018.04.096
– volume: 46
  start-page: 441
  year: 2020
  ident: 1728_CR23
  publication-title: BioFactors
  doi: 10.1002/biof.1599
– volume: 10
  start-page: 446
  year: 2022
  ident: 1728_CR32
  publication-title: Ann Transl Med
  doi: 10.21037/atm-22-1221
– volume: 110
  year: 2020
  ident: 1728_CR2
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2019.102400
– volume: 14
  start-page: 395
  year: 2021
  ident: 1728_CR43
  publication-title: J Inflamm Res
  doi: 10.2147/JIR.S295957
– volume: 910
  year: 2021
  ident: 1728_CR8
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2021.174500
– volume: 418
  start-page: 20
  year: 2018
  ident: 1728_CR16
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2017.12.035
– volume: 27
  start-page: 281
  year: 2018
  ident: 1728_CR10
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2017.10.005
– volume: 65
  start-page: S140
  year: 2007
  ident: 1728_CR29
  publication-title: Nutr Rev
  doi: 10.1301/nr.2007.dec.S140-S146
– volume: 98
  start-page: 3
  year: 2018
  ident: 1728_CR12
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00001.2017
– volume: 13
  start-page: 4987
  year: 2021
  ident: 1728_CR11
  publication-title: Cancers
  doi: 10.3390/cancers13194987
– volume: 12
  start-page: 785586
  year: 2021
  ident: 1728_CR13
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2021.785586
– volume: 661
  start-page: 117
  year: 2019
  ident: 1728_CR35
  publication-title: Arch Biochem Biophys
  doi: 10.1016/j.abb.2018.11.016
– volume: 2020
  start-page: 3830212
  year: 2020
  ident: 1728_CR4
  publication-title: Mediators Inflamm
  doi: 10.1155/2020/3830212
– volume: 12
  start-page: 911
  year: 2018
  ident: 1728_CR34
  publication-title: Front Neurosci
  doi: 10.3389/fnins.2018.00911
– volume: 59
  start-page: 89
  year: 2011
  ident: 1728_CR1
  publication-title: Arch Immunol Ther Exp
  doi: 10.1007/s00005-011-0116-3
– volume: 10
  start-page: 3024
  year: 2017
  ident: 1728_CR20
  publication-title: Sci Signal.
  doi: 10.1126/scisignal.aal3024
– volume: 9
  start-page: 1472
  year: 2018
  ident: 1728_CR42
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2018.01472
– volume: 140
  start-page: 111693
  year: 2021
  ident: 1728_CR33
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2021.111693
– volume: 170
  start-page: 1
  year: 2019
  ident: 1728_CR3
  publication-title: Ann Intern Med
  doi: 10.7326/AITC201901010
– volume: 15
  start-page: 4663
  year: 2022
  ident: 1728_CR14
  publication-title: J Inflamm Res
  doi: 10.2147/JIR.S378090
– volume: 66
  start-page: 12953
  year: 2018
  ident: 1728_CR24
  publication-title: J Agric Food Chem
  doi: 10.1021/acs.jafc.8b05047
– volume: 463
  start-page: 11
  year: 2019
  ident: 1728_CR28
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2019.08.003
– volume: 12
  start-page: 795626
  year: 2022
  ident: 1728_CR15
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.795626
– volume: 15
  start-page: 186
  year: 2015
  ident: 1728_CR22
  publication-title: Endocr Metab Immune Disord Drug Targets
  doi: 10.2174/1871530315666150316120316
– volume: 123
  start-page: 625
  year: 2014
  ident: 1728_CR39
  publication-title: Blood
  doi: 10.1182/blood-2013-09-512749
– volume: 26
  start-page: 7528
  year: 2021
  ident: 1728_CR36
  publication-title: Molecules
  doi: 10.3390/molecules26247528
– volume: 12
  year: 2021
  ident: 1728_CR6
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.686155
– volume: 174
  start-page: 1633
  year: 2017
  ident: 1728_CR17
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.13492
– volume: 14
  start-page: 5101
  year: 2022
  ident: 1728_CR19
  publication-title: Nutrients
  doi: 10.3390/nu14235101
– volume: 46
  year: 2022
  ident: 1728_CR31
  publication-title: J Food Biochem
  doi: 10.1111/jfbc.14182
SSID ssj0008282
Score 2.4679532
Snippet Objective This study investigated the impacts of SIRT1 activation on rheumatoid arthritis (RA)-related angiogenesis. Methods HUVECs were cultured by different...
This study investigated the impacts of SIRT1 activation on rheumatoid arthritis (RA)-related angiogenesis. HUVECs were cultured by different human serum....
ObjectiveThis study investigated the impacts of SIRT1 activation on rheumatoid arthritis (RA)-related angiogenesis.MethodsHUVECs were cultured by different...
This study investigated the impacts of SIRT1 activation on rheumatoid arthritis (RA)-related angiogenesis.OBJECTIVEThis study investigated the impacts of SIRT1...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1021
SubjectTerms Allergology
Angiogenesis
Animals
Arthritis
Arthritis, Rheumatoid - drug therapy
Arthritis, Rheumatoid - metabolism
Biomedical and Life Sciences
Biomedicine
Chromatography, Liquid
Cytokines
Cytokines - metabolism
Dermatology
Energy metabolism
Epithelial cells
Epithelium
Gene expression
Glycolysis
Guanosine Triphosphate - metabolism
Humans
Hypoxia-Inducible Factor 1, alpha Subunit - metabolism
Hypoxia-inducible factor 1a
Immunoblotting
Immunology
Inflammation
Interrupters
Lipopolysaccharides
Lipopolysaccharides - metabolism
Metabolites
Metabolomics
Neovascularization, Pathologic - drug therapy
Neurology
Original Research Paper
Pharmacology/Toxicology
Rats
Resveratrol
Resveratrol - pharmacology
Rheumatoid arthritis
Rheumatology
RhoA protein
Rocks
siRNA
SIRT1 protein
Sirtuin 1 - genetics
Sirtuin 1 - metabolism
Tandem Mass Spectrometry
Vascular endothelial growth factor
Vascular Endothelial Growth Factor A - genetics
Wound healing
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fi9QwEB_0fPFF_G_1lAhyL27g2jRN-3iIy56gHOcu3FtJmmS3sLRH2_XYj-DH8Yv4mZykfxY5FXwrZJIWZjLzm07mF4B3XGU6VSahOoqUKzMqKnUSUckUhj8dsthzd37-kixW8acrfjU0hbXjafexJOk99dTs5uELxRhDXd6S0pu7cI-73B2teBWdTf4Xc4i-xomSmH-dDq0yf17j93B0C2Peqo_6sDN_CA8GvEjOegU_gjumegwnFz3h9H5Glof-qXZGTsjFgYp6_wS-X5r2m6NNbuotxewb9ajJ1_PLZUhcQ0P_O5aU1aZUZdeS9XaPMx1HCbU7jEeayGpd1mvnD8uWuH6zhjQbs0OYW5c42nQbT4pEMKvW_eEvUk4X63aktmRxPqfhzx9PYTX_uPywoMPlC7Rggnc0s6nmUikmQl6wkAkpjYmETpiIs1SLzCZSCoE-QIqisEoXilvLbBhJrm3C2DM4qurKvACC4QBtAJGaTdKYewo-65CHSSU-xSaAcNRBXgzM5O6CjG0-cSp7veWot9zrLb8J4P0057rn5fin9PGo2nzYo20epSF3RchYBPB2Gsbd5UomsjL1DmVEhpAvxaQsgOe9SUyvY8LB5fg0gNloI4fF__4tL_9P_BXcj7y9ujOWx3DUNTvzGnFQp954s_8FEgUBzg
  priority: 102
  providerName: Springer Nature
Title Resveratrol-induced SIRT1 activation inhibits glycolysis-fueled angiogenesis under rheumatoid arthritis conditions independent of HIF-1α
URI https://link.springer.com/article/10.1007/s00011-023-01728-w
https://www.ncbi.nlm.nih.gov/pubmed/37016140
https://www.proquest.com/docview/2815842547
https://www.proquest.com/docview/2796158576
Volume 72
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NjtMwELZg98IF8U-XZWUktBdqsYmTOD2hLmrpgqiq0krlFNmx3UaqkqVJWfUReBxehGdixklToRV7SiTbiaUZe77xeL4h5G2oejpWJmLa9xWGGRWTOvKZ5ArMn_Z44Lg7v46j0Tz4vAgXzYFb2Vyr3O-JbqPWRYpn5O_92AsxZBSID9c_GFaNwuhqU0LjPjlG6jK80iUWrcOF7Gx1tNPnDDyxiyZpxqXOOTDEsAW9oJjd_GuYbqHNW5FSZ4CGj8jDBjnSfi3qx-SeyZ-Q80lNPb3r0tkhk6rs0nM6OZBS756SX1NT_kQC5U2xZuCHg0Q1_XY1nXkUUxvqg1ma5atMZVVJl-sdjES2Ema3YJk0lfkyK5a4M2YlxcyzDd2szBYAb5FB66ZaOXokCv61rq-B0awtsVvRwtLR1ZB5f34_I_PhYPZxxJoyDCzlIqxYz8Y6lEpx4YUp97iQ0hhf6IiLoBdr0bORlELAbiBFmlqlUxVay63ny1DbiPPn5CgvcvOSUDAMoA2A2WwUB6Ej47OIQUws4S0wHeLtZZCkDUc5lspYJy27spNbAnJLnNySmw551465rhk67ux9uhdt0qzWMjnoVoe8aZthnWHwROam2EIf0QPwF4N71iEvapVof8cFAufgokO6ex05fPz_czm5ey6vyAPf6SferjwlR9Vma14DAqrUmVPzM3LcH15ejvH56fuXATwvB-PJFFrnfv8vSjEKHA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF5V6QEuiH9MCywS9EJW1F7bax8Q4qdRQtsoCqnUm7vr3U0sRXZrO0R5BF4GiRfhmZj1X4Qqeust0tqOpfk8883OzjcIvfFEKAOhfCIdR5gyoyBc-g7hVED4kzZ1K-3O07E_PHO_nXvnO-hX2wtjjlW2PrFy1DKLzR75eyewPVMyctnHyytipkaZ6mo7QqOGxbHarCFlKz6MvoJ93zrO4Gj2ZUiaqQIkpswrSagD6XEhKLO9mNqUca6Uw6RPmRsGkoXa55wxADdncayFjIWnNdW2wz2pfbMBCi5_16WQyvTQ7uej8WTa-X7IX-r6qkMJ5H6HTZtO1axX0S9iVkzeFZD1v6HwGr-9VputQt7gPrrXcFX8qQbXA7Sj0ofoYFKLXW_6eLbt3Sr6-ABPtjLYm0fo51QVP4xkc54tCWT-gCGJv4-mMxubZop6Kxgn6SIRSVng-XIDdxp9FKJXEAsl5uk8yebGFycFNr1uOc4XagUUO0tgNS8XlSAThoxe1gfPcNIN9S1xpvFwNCD2n9-P0dmtmOgJ6qVZqp4hDKEI8AcsUfuB61Xyf9qwHhVw-OUqC9mtDaK4UUU3wzmWUafnXNktArtFld2itYXedfdc1pogN16935o2avxDEW3RbKHX3TJ82aZcw1OVreAaFgLdDCAhtNDTGhLd31FmqLp7aKF-i5Htw___Ls9vfpdX6M5wdnoSnYzGx3vorlNh1Zzt3Ee9Ml-pF8C_SvGyAT1GF7f9nf0FqLJEhA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dbtMwFLamISFuEP8UBhgJdkOtLXESpxcIIUbVMpiq0Um7C3Zst5GqZDQpVR-Bx-GWh-CZOMf5qdDE7nYXyXYS6Xw-Pz4-3yHkVagGOlYmYtr3FaYZFZM68pnkCsyf9njguDu_nESjs-DTeXi-Q363tTB4rbLViU5R6yLFM_IDP_ZCTBkF4sA21yImR8N3F98ZdpDCTGvbTqOGyLHZrCF8K9-Oj0DWr31_-HH6YcSaDgMs5SKs2MDGOpRKceGFKfe4kNIYX-iIi2AQazGwkZRCANClSFOrdKpCa7n1fBlqG-FhKKj_G4KHHu4xcd4Fe8gMV2dafc4gCjxsCnZc2Z5zxBiOYAQWs_W_RvGSp3spS-uM3_AOud14rfR9DbO7ZMfk98j-pKa93vTpdFvFVfbpPp1sCbE398nPU1P-QPLmZbFgWa4BTZp-HZ9OPYplFfWhMM3yeaayqqSzxQZWIlMKsyuwiprKfJYVM9TKWUmx6m1Jl3OzAme7yGB0Wc0dNROF2F7XV9Bo1rX3rWhh6Wg8ZN6fXw_I2bUI6CHZzYvcPCYUjBIgEfxFG8VB6IgALfo_JpbwFJge8VoZJGnDj45tOhZJx-zs5JaA3BInt2TdI2-6NRc1O8iVs_da0SaNpiiTLa575GU3DHscEzcyN8UK5ogBOJ4xhIY98qiGRPc5LtBpDw57pN9iZPvy___Lk6v_5QW5Cbsr-Tw-OX5KbvkOqnjJc4_sVsuVeQaOWKWeO8RT8u26t9hfGkJHVA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Resveratrol-induced+SIRT1+activation+inhibits+glycolysis-fueled+angiogenesis+under+rheumatoid+arthritis+conditions+independent+of+HIF-1%CE%B1&rft.jtitle=Inflammation+research&rft.au=Jiang%2C+Tian-Tian&rft.au=Ji%2C+Cong-Lan&rft.au=Yu%2C+Li-Jun&rft.au=Song%2C+Meng-Ke&rft.date=2023-05-01&rft.pub=Springer+Nature+B.V&rft.issn=1023-3830&rft.eissn=1420-908X&rft.volume=72&rft.issue=5&rft.spage=1021&rft.epage=1035&rft_id=info:doi/10.1007%2Fs00011-023-01728-w&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1023-3830&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1023-3830&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1023-3830&client=summon